Skip to content

Paolo Brambilla

10 papers in the library · 199 citations · publishing 2010-2026

Papers

Sort Most recent Most cited

The neurobiological basis of the awe experience in affective disorders: an exploratory EEG study

Frontiers in Systems Neuroscience June 4, 2026 Elena Bondi, Flavia Carbone, Giandomenico Schiena et al.

Introduction: Affective disorders (ADs) are characterized by profound emotional processing deficits involving disrupted neural network activity and connectivity, particularly within the default mode network and fronto-temporal circuits, with abnormalities in theta and alpha oscillatory patterns. While current treatments primarily target mood symptoms, emotional processing impairments often...

EEG signature in psychiatrist's subjective experience: a pilot study.

Frontiers in Psychiatry 2026 Giovanni Videtta, Elena Bondi, Chiara Colli et al.

The Assessment of Clinician's Subjective Experience (ACSE) is a self-report questionnaire developed to evaluate clinicians' subjective experiences during patient interactions. While its psychometric properties and clinical validity have been supported, its neurobiological correlates have not yet been investigated. In this pilot study, two clinicians and ten patients participated in a...

DOI: 10.3389/fpsyt.2026.1933800 (opens in new tab) Full text (opens in new tab) Phenomenology Electroencephalography Intersubjectivity Neurobiological correlates +1

Effect of ketamine on task-based functional magnetic resonance imaging findings in major depressive disorder: A mini-review.

Journal of Affective Disorders February 1, 2025 Farzaneh Ramezani, Peyman Mardani, Fatemeh Nemati et al. 4 citations

Over the last two decades, ketamine has gained significant interest in psychiatry as a potential treatment for major depressive disorder (MDD), especially in individuals who are resistant to traditional therapies or are at a high risk of suicide. Task-based functional magnetic resonance imaging (fMRI) studies can provide insight into how ketamine alters brain function and contributes to its...

Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals

EClinicalMedicine September 8, 2023 Mathilde Argote, Guillaume Sescousse, Jérôme Brunelin et al. 31 citations

Background: The association between cannabis use and positive symptoms in schizophrenia spectrum disorders is well documented, especially via meta-analyses. Yet, findings are inconsistent regarding negative symptoms, while other dimensions such as disorganization, depression, and excitement, have not been investigated. In addition, meta-analyses use aggregated data discarding important...

Substance-Induced Psychoses: An Updated Literature Review

Frontiers in Psychiatry December 23, 2021 A. Fiorentini, Filippo Cantù, Camilla Crisanti et al. 123 citations

Background: On the current psychopharmacological panorama, the variety of substances able to provoke an episode of acute psychosis is rapidly increasing. Such psychotic episodes are classified according to the major category of symptoms: positive, negative, or cognitive psychotic episodes. On one hand, the abuse of methamphetamines, cannabis, and cocaine plays a big role in increasing the...

Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis

Neuropsychopharmacology March 3, 2021 Nora Penzel, Linda A. Antonucci, Linda T. Betz et al. 18 citations

Cannabis use during adolescence is associated with an increased risk of developing psychosis. According to a current hypothesis, this results from detrimental effects of early cannabis use on brain maturation during this vulnerable period. However, studies investigating the interaction between early cannabis use and brain structural alterations hitherto reported inconclusive findings. We...

DOI: 10.1038/s41386-021-00977-9 (opens in new tab) Full text (opens in new tab) Psychosis Schizophrenia object-oriented programming Confounding Age of onset +4

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Journal of Visualized Experiments August 18, 2020 Giuseppe Delvecchio, Lucio Oldani, Gian Mario Mandolini et al. 3 citations

Cannabis is the illicit drug most commonly used worldwide, and its consumption can both induce psychiatric symptoms in otherwise healthy subjects and unmask a florid psychotic picture in patients with a prior psychotic risk. Previous studies suggest that chronic and long-term cannabis exposure may exert significant negative effects in brain areas enriched with cannabinoid receptors. However,...

Genetic and environmental bases of the interplay between magical ideation and personality.

Psychiatry Research February 28, 2014 Paolo Brambilla, Corrado Fagnani, Filippo Cecchetto et al.

Sub-threshold psychotic symptoms are quite commonly present in general population. Among these, Magical Ideation (MI) has been proved to be a valid predictor of psychosis. However, the genetic and environmental influences on the interplay between MI and personality have not fully been explored. A total of 534 adult twins from the population-based Italian Twin Register were assessed for MI using...

DOI: 10.1016/j.psychres.2013.11.021 (opens in new tab) Full text (opens in new tab) Magical ideation Psychosis Schizotypy Self-directedness +2

Functional neural correlates of mindfulness meditations in comparison with psychotherapy, pharmacotherapy and placebo effect. Is there a link?

Acta Neuropsychiatrica June 2010 Alberto Chiesa, Paolo Brambilla, Alessandro Serretti

Chiesa A, Brambilla P, Serretti A. Functional neural correlates of mindfulness meditations in comparison with psychotherapy, pharmacotherapy and placebo effect. Is there a link? Mindfulness meditations (MM) are a group of meditation practices which are increasingly receiving attention. The aim of the present work is to review current findings about the neural correlates of MM and compare such...